Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

2.36
Delayed Data
As of 3:59pm ET
 +0.0699 / +3.05%
Today’s Change
1.27
Today|||52-Week Range
7.10
+66.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization37.1K28.3K27.5K32.9K
 
 
 
 
 
 
Operating ExpensesGross Income-37.1K-28.3K-27.5K-32.9K
 
 
 
 
 
General Expenses7.9M13.2M18.2M16.4M
 
 
 
 
 
Research And Development3.3M7.0M12.1M10.1M
 
 
 
 
 
Total Operating Expenses8.0M13.3M18.3M16.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-8.0M-13.3M-18.3M-16.4M
 
 
 
 
 
Extraordinary Credit0.000.004.0M7.3M
 
 
 
Extraordinary Charge-1.4M-5.2M0.000.00
 
 
 
Interest Expense On Debt0.000.000.00313.1K
 
 
Other Expenses-204.2K-206.2K-211.1K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-9.5M-18.5M-14.4M-9.3M
 
 
 
 
 
Net Income-9.5M-18.5M-14.4M-9.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.9M17.6M18.2M21.7M
 
 
 
 
 
Shares To Calculate EPS Diluted12.9M17.6M18.2M21.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.70-$1.10-$0.80-$0.40
 
 
 
 
 
EPS Diluted-$0.70-$1.10-$0.80-$0.40